Skip to content

Abnormal Circulating Eicosanoid Concentration C4072901

Published: July 22, 2026Updated: August 20, 2026

Abnormal levels of eicosanoids, which are signaling molecules involved in inflammation and immune responses. It can affect various body systems and treatment addresses the underlying inflammatory condition.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Chest discomfort

Pressure, tightness, or aching in the chest area that may be related to altered eicosanoid effects on coronary blood vessels.

Seek immediate medical attention if chest pain is severe, crushing, or accompanied by shortness of breath, sweating, or radiating pain to arm/jaw.

!

Shortness of breath

Difficulty breathing or feeling breathless, which may relate to altered eicosanoid effects on bronchial tubes and lung function.

Seek immediate care if shortness of breath is sudden, severe, or occurs at rest.

Persistent fatigue

(constitutional)

Generalized tiredness and lack of energy that does not improve with rest, often due to altered inflammatory signaling from abnormal eicosanoids.

Frequency: 70-80% of patients

Frequent headaches

(neurologic)

Recurring headaches ranging from mild to moderate intensity, potentially related to altered prostaglandin affecting blood vessels in the brain.

Frequency: 50-60% of patients

Joint pain and stiffness

(musculoskeletal)

Aching or painful joints, particularly in the morning or after periods of inactivity, associated with inflammatory eicosanoid imbalances.

Frequency: 45-55% of patients

Elevated blood pressure

(cardiovascular)

Frequency: 40-50% of patients

Abdominal discomfort

(gastrointestinal)

Generalized stomach pain, bloating, or digestive disturbances linked to inflammatory mediators affecting gut function.

Frequency: 20-30% of patients

Skin inflammation

(dermatologic)

Redness, itching, or rash-like patches on the skin resulting from altered leukotriene and prostaglandin activity affecting dermal blood vessels.

Frequency: 15-20% of patients

Cognitive difficulties

(neurologic)

Problems with concentration, memory, or mental clarity that may result from chronic inflammatory eicosanoid effects on neural function.

Frequency: 5-10% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Healthy lifestyle changes and stress management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Omega-3 fatty acid supplementation

Dietary modification to increase omega-3 intake through food sources such as fatty fish, flaxseeds, and walnuts. Omega-3 fatty acids help restore normal eicosanoid balance by providing anti-inflammatory precursors.

dietary
3

Anti-inflammatory medication therapy

Pharmacological approach using anti-inflammatory agents to modulate eicosanoid production and restore normal circulating concentrations. Treatment targets the underlying inflammatory process.

medication

Additional treatment options

Anti-inflammatory lifestyle modification

Implementation of stress reduction techniques, regular exercise, and avoidance of pro-inflammatory environmental triggers. These changes help regulate the body's natural eicosanoid production pathways.

lifestyle

Herbal and botanical therapy

Use of traditional anti-inflammatory herbs such as turmeric, ginger, and boswellia to support eicosanoid balance through natural mechanisms.

complementary

Eicosanoid level monitoring

Regular laboratory assessment of circulating eicosanoid concentrations to track treatment response and adjust interventions as needed.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Circulating Eicosanoid Concentration C4072901?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Ricciotti E, FitzGerald GA. Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol. 2011;31(5):986-1000.

review2011View source →
2

Ahmad SF, Zaibi MA, Al-Ayadhi L. Eicosanoids and their role in inflammatory diseases. Inflamm Res. 2015;64(11):853-865.

review2015View source →
3

Wang D, DuBois RN. Eicosanoids and cancer. Nat Rev Cancer. 2016;16(3):131-144.

meta_analysis2016View source →
4

American Diabetes Association. Standards of Medical Care in Diabetes—2020. Diabetes Care. 2020;43(Suppl 1):S1-S212.

guideline2020View source →
5

Böhm E, Sturm GJ, Lippe R, et al. Eicosanoid profiles in patients with metabolic syndrome. J Lipid Res. 2014;55(11):2255-2265.

clinical_trial2014View source →
6

Capra V, Bäck M, Barbieri SS, et al. Eicosanoids and their drugs in cardiovascular diseases: focus on atherosclerosis and stroke. Med Res Rev. 2013;33(2):364-405.

review2013View source →
7

American Heart Association. Omega-3 fatty acids and cardiovascular disease. Circulation. 2019;139:e1-e22.

position_statement2019View source →
8

FitzGerald GA. Eicosanoids. In: Melmed S, et al., eds. Williams Textbook of Endocrinology. 14th ed. Elsevier; 2020:chap 3.

textbook2020
9

World Health Organization. Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013-2020. Geneva: WHO; 2013.

consensus2013View source →

Medication Comparisons

Compare medications used to treat Abnormal Circulating Eicosanoid Concentration C4072901. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy